KBC Group
RGEN icon

KBC Group’s Repligen RGEN Stock Holding History

KBC Group’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Buy
1,837
+315
+21% +$44K ﹤0.01% 952
2025
Q4 		$249K Hold
1,522
– – ﹤0.01% 836
2025
Q3 		$203K Hold
1,522
– – ﹤0.01% 898
2025
Q2 		$189K Sell
1,522
-1,022
-40% -$130K ﹤0.01% 887
2025
Q1 		$324K Buy
2,544
+329
+15% +$50.6K ﹤0.01% 824
2024
Q4 		$319K Sell
2,215
-754
-25% -$108K ﹤0.01% 917
2024
Q3 		$442K Sell
2,969
-5,483
-65% -$786K ﹤0.01% 733
2024
Q2 		$1.06M Buy
8,452
+66
+0.8% +$10.3K ﹤0.01% 655
2024
Q1 		$1.54M Buy
8,386
+219
+3% +$41.7K ﹤0.01% 619
2023
Q4 		$1.47M Sell
8,167
-32,185
-80% -$5.01M 0.01% 646
2023
Q3 		$6.42M Buy
40,352
+19,318
+92% +$3.16M 0.03% 415
2023
Q2 		$2.98M Buy
21,034
+2,157
+11% +$346K 0.01% 542
2023
Q1 		$3.18M Buy
18,877
+15,425
+447% +$2.75M 0.01% 576
2022
Q4 		$585K Buy
+3,452
New +$626K ﹤0.01% 742
2019
Q4 		– Sell
-30,929
Closed -$2.37M – 1539
2019
Q3 		$2.37M Buy
30,929
+13,617
+79% +$1.19M 0.02% 600
2019
Q2 		$1.49M Hold
17,312
– – 0.01% 700
2019
Q1 		$1.02M Buy
+17,312
New +$996K 0.01% 853
2016
Q3 		– Sell
-2,354
Closed -$64K – 1304
2016
Q2 		$64K Hold
2,354
– – ﹤0.01% 1203
2016
Q1 		$63K Hold
2,354
– – ﹤0.01% 1182
2015
Q4 		$67K Hold
2,354
– – ﹤0.01% 1149
2015
Q3 		$66K Sell
2,354
-1,145
-33% -$41.4K ﹤0.01% 1187
2015
Q2 		$144K Hold
3,499
– – ﹤0.01% 1184
2015
Q1 		$106K Hold
3,499
– – ﹤0.01% 1214
2014
Q4 		$69K Hold
3,499
– – ﹤0.01% 1346
2014
Q3 		$70K Buy
+3,499
New +$73.6K ﹤0.01% 1177

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KBC Group's RGEN Position: Q1 2026 in Review

KBC Group increased its Repligen (RGEN) stake by 21% in Q1 2026, buying an estimated $44K and bringing the position to 1,837 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

KBC Group first reported a position in RGEN in Q3 2014 and has held it in 25 quarters since. The position peaked at $6.42M in Q3 2023. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • KBC Group held 1,837 shares of Repligen worth $216K as of Q1 2026.
  • KBC Group bought 315 Repligen shares in Q1 2026, an estimated $44K.
  • Repligen made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #952 holding.
  • KBC Group first reported a position in Repligen in Q3 2014 and has held it in 25 quarters since.
  • KBC Group's Repligen position peaked at $6.42M in Q3 2023.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.